Chemotherapy strategy for colorectal cancer under the outbreak of novel coronavirus pneumonia
10.3760/cma.j.cn.441530-20200226-00093
- VernacularTitle: 新型冠状病毒肺炎疫情下的结直肠癌患者化疗策略
- Author:
Yanhao LI
1
;
Lin SHEN
1
;
Jian LI
1
Author Information
1. Department of Gastrointestinal Cancer, Peking University Cancer Hospital & Institute, Key Laboratory of Carcinogenesis and Translational Research (Ministry of Education), Bejing 100142, China
- Publication Type:Journal Article
- Keywords:
Novel coronavirus pneumonia (NCP);
Colorectal neoplasms;
Chemotherapy
- From:
Chinese Journal of Gastrointestinal Surgery
2020;23(0):E004-E004
- CountryChina
- Language:Chinese
-
Abstract:
The outbreak of novel coronavirus pneumonia (NCP) makes the medical treatment of colorectal cancers difficult. Cancer patients are more susceptible to infection and tumor history is defined as an important factor of poor prognosis, which challenges both doctors and patients. For metastatic colorectal cancer (CRC) patients, maintenance therapy is the optimal choice. The patients with tumor progression or poor biological behaviorshould receive or or continue combination chemotherapy. Adjuvant chemotherapy should reduce the intensity of treatment and shorten the therapy time. Fever patients during chemotherapy need to receive differential diagnosis and screening according to national standards. Patients with stable diseases and good general conditions may delay imaging examination.. Clinicians should make individual clinical decisions based on the specifics of each patient durding epidemic situation.
